BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35032556)

  • 1. Implications for the metabolic fate of oral glutamine supplementation within plasma and erythrocytes of patients with sickle cell disease: A pharmacokinetics study.
    Morris CR; Kuypers FA; Hagar R; Larkin S; Lavrisha L; Saulys A; Vichinsky EP; Suh JH
    Complement Ther Med; 2022 Mar; 64():102803. PubMed ID: 35032556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of glutamine supplementation on markers of apoptosis and autophagy in sickle cell disease peripheral blood mononuclear cells.
    Walter PB; Hohman LS; Rokeby A; Lum JJ; Hagar R; Lavrisha L; Saulys A; Kuypers FA; Vichinsky E; Morris CR
    Complement Ther Med; 2022 Nov; 70():102856. PubMed ID: 35843474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral arginine supplementation on exhaled nitric oxide concentration in sickle cell anemia and acute chest syndrome.
    Sullivan KJ; Kissoon N; Sandler E; Gauger C; Froyen M; Duckworth L; Brown M; Murphy S
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):e249-58. PubMed ID: 20724949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-glutamine for sickle cell disease: more than reducing redox.
    Jafri F; Seong G; Jang T; Cimpeanu E; Poplawska M; Dutta D; Lim SH
    Ann Hematol; 2022 Aug; 101(8):1645-1654. PubMed ID: 35568758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease.
    Morris CR; Suh JH; Hagar W; Larkin S; Bland DA; Steinberg MH; Vichinsky EP; Shigenaga M; Ames B; Kuypers FA; Klings ES
    Blood; 2008 Jan; 111(1):402-10. PubMed ID: 17848621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.
    Morris CR; Kato GJ; Poljakovic M; Wang X; Blackwelder WC; Sachdev V; Hazen SL; Vichinsky EP; Morris SM; Gladwin MT
    JAMA; 2005 Jul; 294(1):81-90. PubMed ID: 15998894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy.
    Little JA; Hauser KP; Martyr SE; Harris A; Maric I; Morris CR; Suh JH; Taylor J; Castro O; Machado R; Kato G; Gladwin MT
    Eur J Haematol; 2009 Apr; 82(4):315-21. PubMed ID: 19215288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-Glutamine in sickle cell disease.
    Cox SE; Hart E; Kirkham FJ; Stotesbury H
    Drugs Today (Barc); 2020 Apr; 56(4):257-268. PubMed ID: 32309821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The feeding route (enteral or parenteral) affects the plasma response of the dipetide Ala-Gln and the amino acids glutamine, citrulline and arginine, with the administration of Ala-Gln in preoperative patients.
    Melis GC; Boelens PG; van der Sijp JR; Popovici T; De Bandt JP; Cynober L; van Leeuwen PA
    Br J Nutr; 2005 Jul; 94(1):19-26. PubMed ID: 16115328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral L-glutamine therapy for sickle cell anemia: I. Subjective clinical improvement and favorable change in red cell NAD redox potential.
    Niihara Y; Zerez CR; Akiyama DS; Tanaka KR
    Am J Hematol; 1998 Jun; 58(2):117-21. PubMed ID: 9625578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of a non-invasive oral nitrate stable isotopic method suggests that arginine and citrulline supplementation increases whole-body NO production in Tanzanian children with sickle cell disease.
    Marealle AI; Siervo M; Wassel S; Bluck L; Prentice AM; Minzi O; Sasi P; Kamuhabwa A; Soka D; Makani J; Cox SE
    Nitric Oxide; 2018 Apr; 74():19-22. PubMed ID: 29305240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of glutamine and glutamate ingestion in healthy subjects and in persons with chronic obstructive pulmonary disease.
    Rutten EP; Engelen MP; Wouters EF; Schols AM; Deutz NE
    Am J Clin Nutr; 2006 Jan; 83(1):115-23. PubMed ID: 16400059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Population Pharmacokinetic Analysis of L-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects.
    Sadaf A; Dong M; Pfeiffer A; Latham T; Kalfa T; Vinks AA; Ware RE; Quinn CT
    Clin Pharmacokinet; 2024 Mar; 63(3):357-365. PubMed ID: 38401036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral citrulline supplementation on whole body protein metabolism in adult patients with short bowel syndrome: A pilot, randomized, double-blind, cross-over study.
    Jirka A; Layec S; Picot D; Bernon-Ferreira S; Grasset N; Flet L; Thibault R; Darmaun D
    Clin Nutr; 2019 Dec; 38(6):2599-2606. PubMed ID: 30642738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coenzyme Q10 in plasma and erythrocytes: comparison of antioxidant levels in healthy probands after oral supplementation and in patients suffering from sickle cell anemia.
    Niklowitz P; Menke T; Wiesel T; Mayatepek E; Zschocke J; Okun JG; Andler W
    Clin Chim Acta; 2002 Dec; 326(1-2):155-61. PubMed ID: 12417107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of citrulline availability in humans.
    Rougé C; Des Robert C; Robins A; Le Bacquer O; Volteau C; De La Cochetière MF; Darmaun D
    Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G1061-7. PubMed ID: 17901164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Supplementation with Beta-Hydroxy-Beta-Methylbutyrate, Arginine, and Glutamine Improves Lean Body Mass in Healthy Older Adults.
    Ellis AC; Hunter GR; Goss AM; Gower BA
    J Diet Suppl; 2019; 16(3):281-293. PubMed ID: 29672184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal supplementation with citrulline or arginine during gestation impacts fetal amino acid availability in a model of intrauterine growth restriction (IUGR).
    Bourdon A; Hannigsberg J; Misbert E; Tran TN; Amarger V; Ferchaud-Roucher V; Winer N; Darmaun D
    Clin Nutr; 2020 Dec; 39(12):3736-3743. PubMed ID: 32336525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-citrulline-malate influence over branched chain amino acid utilization during exercise.
    Sureda A; Córdova A; Ferrer MD; Pérez G; Tur JA; Pons A
    Eur J Appl Physiol; 2010 Sep; 110(2):341-51. PubMed ID: 20499249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulatory effects of arginine, glutamine and branched-chain amino acids on heat shock proteins, immunity and antioxidant response in exercised rats.
    Moura CS; Lollo PCB; Morato PN; Risso EM; Amaya-Farfan J
    Food Funct; 2017 Sep; 8(9):3228-3238. PubMed ID: 28812766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.